Webinar | What’s Behind the Evidence Bar™ (a two-part series)

July 23 & July 30 at 11:00 a.m. ET


Members often ask us for deeper insight about how we arrive at conclusions featured in The Evidence Bar™, ECRI’s proprietary visual, at-a-glance graphic, which summarizes our judgment of a body of clinical evidence. This two-part webinar is an opportunity to gain that insight.

The Evidence Bar is intended to help healthcare professionals efficiently make evidence-based decisions about healthcare technologies and interventions. Whether the decision is for value analysis projects, developing clinical protocols or care processes, or making coverage decisions, The Evidence Bar helps users quickly determine the potential benefits and harms of healthcare technologies and interventions.

In this two-part series, the Director of ECRI’s Clinical Evidence Assessment service will be joined by a Senior Research Analyst to discuss how ECRI research analysts clarify custom research questions and create the framework to perform clinical evidence review of medical devices, pharmaceuticals, procedures, and care processes. You’ll gain insight into how we assess the quality of evidence to assign The Evidence Bar.

  • What’s Behind the Evidence Bar: Part 1, scheduled on July 23 will focus on the myriad of factors we consider, how we set up the analytic framework, how we weigh benefits and harms, and what each of seven evidence bar choices means.
  • What’s Behind the Evidence Bar: Part 2, scheduled on July 30 will focus on five case studies of different interventions/technologies to give you insight into how The Evidence Bars were assigned.

Join us at these informative sessions. Come with your questions. See what’s behind The Evidence Bar that enables you to be confident about your evidence-based decisions.

Learning objectives:

  1. Understand how key questions posed about an intervention or technology inform the search for evidence for rapid clinical evidence assessments
  2. Understand how we determine study inclusion/exclusion criteria for rapid clinical evidence assessments
  3. Identify risk of bias and other factors ECRI analysts consider when assessing safety and effectiveness
  4. Understand how these considerations inform choosing The Evidence Bar™

Agenda & Speakers

Diane Robertson

Director, Clinical Evidence Assessment

Savvas Pavlides, PhD

Scientific Quality Manager, Technology Assessment

Jesse Munn

Associate Director, Clinical Evidence Assessment